vs
CUMBERLAND PHARMACEUTICALS INC（CPIX）与NexPoint Real Estate Finance, Inc.（NREF）财务数据对比。点击上方公司名可切换其他公司
CUMBERLAND PHARMACEUTICALS INC的季度营收约是NexPoint Real Estate Finance, Inc.的1.2倍（$13.7M vs $11.1M），NexPoint Real Estate Finance, Inc.净利率更高（216.6% vs -10.3%，领先226.9%），CUMBERLAND PHARMACEUTICALS INC同比增速更快（31.1% vs -48.8%）
坎伯兰制药是一家专科制药企业，专注于开发、生产和商业化品牌处方药物，核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域，主要运营市场为美国，为相关医护人员与患者提供服务。
NexPoint Real Estate Finance, Inc.是一家总部位于美国的商业地产金融企业，主要为多户住宅、写字楼、工业及酒店物业提供结构化融资方案，运营并管理抵押贷款及其他地产相关投资组合，为利益相关方提供经风险调整的稳定回报。
CPIX vs NREF — 直观对比
营收规模更大
CPIX
是对方的1.2倍
$11.1M
营收增速更快
CPIX
高出79.9%
-48.8%
净利率更高
NREF
高出226.9%
-10.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.7M | $11.1M |
| 净利润 | $-1.4M | $24.0M |
| 毛利率 | 83.6% | — |
| 营业利润率 | -10.0% | — |
| 净利率 | -10.3% | 216.6% |
| 营收同比 | 31.1% | -48.8% |
| 净利润同比 | 25.8% | 58.7% |
| 每股收益（稀释后） | $-0.09 | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPIXNREF
| Q4 25 | $13.7M | $11.1M | ||
| Q3 25 | $8.3M | $12.5M | ||
| Q2 25 | $10.8M | $12.1M | ||
| Q1 25 | $11.7M | $11.5M | ||
| Q4 24 | $10.4M | $21.7M | ||
| Q3 24 | $9.1M | $12.5M | ||
| Q2 24 | $9.8M | $6.7M | ||
| Q1 24 | $8.5M | $-12.8M |
净利润CPIXNREF
| Q4 25 | $-1.4M | $24.0M | ||
| Q3 25 | $-1.9M | $50.9M | ||
| Q2 25 | $-740.7K | $22.3M | ||
| Q1 25 | $1.3M | $26.0M | ||
| Q4 24 | $-1.9M | $15.2M | ||
| Q3 24 | $-1.5M | $23.3M | ||
| Q2 24 | $-1.1M | $12.1M | ||
| Q1 24 | $-1.9M | $-14.6M |
毛利率CPIXNREF
| Q4 25 | 83.6% | — | ||
| Q3 25 | 88.1% | — | ||
| Q2 25 | 81.4% | — | ||
| Q1 25 | 87.8% | — | ||
| Q4 24 | 81.1% | — | ||
| Q3 24 | 85.4% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 81.5% | — |
营业利润率CPIXNREF
| Q4 25 | -10.0% | — | ||
| Q3 25 | -23.7% | — | ||
| Q2 25 | -6.9% | — | ||
| Q1 25 | 11.0% | — | ||
| Q4 24 | -17.7% | — | ||
| Q3 24 | -18.6% | — | ||
| Q2 24 | -10.4% | — | ||
| Q1 24 | -22.0% | — |
净利率CPIXNREF
| Q4 25 | -10.3% | 216.6% | ||
| Q3 25 | -23.4% | 407.0% | ||
| Q2 25 | -6.8% | 184.5% | ||
| Q1 25 | 10.7% | 225.6% | ||
| Q4 24 | -18.2% | 69.9% | ||
| Q3 24 | -17.0% | 186.4% | ||
| Q2 24 | -11.0% | 179.7% | ||
| Q1 24 | -22.9% | 114.3% |
每股收益（稀释后）CPIXNREF
| Q4 25 | $-0.09 | $0.47 | ||
| Q3 25 | $-0.13 | $1.14 | ||
| Q2 25 | $-0.05 | $0.54 | ||
| Q1 25 | $0.08 | $0.70 | ||
| Q4 24 | $-0.13 | $0.71 | ||
| Q3 24 | $-0.11 | $0.74 | ||
| Q2 24 | $-0.08 | $0.40 | ||
| Q1 24 | $-0.14 | $-0.83 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | $31.1M |
| 总债务越低越好 | — | $771.2M |
| 股东权益账面价值 | $24.9M | $388.0M |
| 总资产 | $76.8M | $5.3B |
| 负债/权益比越低杠杆越低 | — | 1.99× |
8季度趋势，按日历期对齐
现金及短期投资CPIXNREF
| Q4 25 | $11.4M | $31.1M | ||
| Q3 25 | $15.2M | $17.9M | ||
| Q2 25 | $16.1M | $9.1M | ||
| Q1 25 | $15.1M | $19.2M | ||
| Q4 24 | $18.0M | $3.9M | ||
| Q3 24 | $17.5M | $34.7M | ||
| Q2 24 | $17.3M | $4.3M | ||
| Q1 24 | $18.5M | $13.5M |
总债务CPIXNREF
| Q4 25 | — | $771.2M | ||
| Q3 25 | — | $720.9M | ||
| Q2 25 | — | $815.6M | ||
| Q1 25 | — | $831.5M | ||
| Q4 24 | — | $799.3M | ||
| Q3 24 | — | $815.5M | ||
| Q2 24 | — | $861.0M | ||
| Q1 24 | — | $843.3M |
股东权益CPIXNREF
| Q4 25 | $24.9M | $388.0M | ||
| Q3 25 | $26.1M | $375.4M | ||
| Q2 25 | $28.0M | $348.2M | ||
| Q1 25 | $28.7M | $343.7M | ||
| Q4 24 | $22.9M | $336.5M | ||
| Q3 24 | $24.8M | $335.8M | ||
| Q2 24 | $26.3M | $327.5M | ||
| Q1 24 | $27.5M | $327.1M |
总资产CPIXNREF
| Q4 25 | $76.8M | $5.3B | ||
| Q3 25 | $65.9M | $5.3B | ||
| Q2 25 | $67.9M | $5.4B | ||
| Q1 25 | $69.9M | $5.4B | ||
| Q4 24 | $75.6M | $5.4B | ||
| Q3 24 | $76.7M | $5.7B | ||
| Q2 24 | $78.5M | $6.6B | ||
| Q1 24 | $81.5M | $7.1B |
负债/权益比CPIXNREF
| Q4 25 | — | 1.99× | ||
| Q3 25 | — | 1.92× | ||
| Q2 25 | — | 2.34× | ||
| Q1 25 | — | 2.42× | ||
| Q4 24 | — | 2.38× | ||
| Q3 24 | — | 2.43× | ||
| Q2 24 | — | 2.63× | ||
| Q1 24 | — | 2.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0K | $-4.5M |
| 自由现金流经营现金流 - 资本支出 | $3.0K | — |
| 自由现金流率自由现金流/营收 | 0.0% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | -0.19× |
| 过去12个月自由现金流最近4个季度 | $4.8M | — |
8季度趋势，按日历期对齐
经营现金流CPIXNREF
| Q4 25 | $3.0K | $-4.5M | ||
| Q3 25 | $187.2K | $8.1M | ||
| Q2 25 | $843.8K | $3.3M | ||
| Q1 25 | $3.9M | $16.0M | ||
| Q4 24 | $1.9M | $4.4M | ||
| Q3 24 | $475.5K | $14.7M | ||
| Q2 24 | $-855.7K | $-7.5M | ||
| Q1 24 | $-2.1M | $17.7M |
自由现金流CPIXNREF
| Q4 25 | $3.0K | — | ||
| Q3 25 | $163.4K | — | ||
| Q2 25 | $817.3K | — | ||
| Q1 25 | $3.9M | — | ||
| Q4 24 | $1.9M | — | ||
| Q3 24 | $460.1K | — | ||
| Q2 24 | $-862.8K | — | ||
| Q1 24 | $-2.2M | — |
自由现金流率CPIXNREF
| Q4 25 | 0.0% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 7.5% | — | ||
| Q1 25 | 32.9% | — | ||
| Q4 24 | 18.2% | — | ||
| Q3 24 | 5.1% | — | ||
| Q2 24 | -8.8% | — | ||
| Q1 24 | -25.6% | — |
资本支出强度CPIXNREF
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.5% | — |
现金转化率CPIXNREF
| Q4 25 | — | -0.19× | ||
| Q3 25 | — | 0.16× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | 3.10× | 0.62× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | 0.63× | ||
| Q2 24 | — | -0.62× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
